Source: Annual Congress 2002 - Lung Physiology: clinical
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. P. Swanney, L. E. Beckert, L. A. Wallace, R. L. Jensen, R. O. Crapo (Christchurch, New Zealand; Salt Lake City, United States Of America). FEV₆ is an acceptable surrogate for FVC in the exclusion of restriction. Eur Respir J 2002; 20: Suppl. 38, 1885

Member's Comments

No comment yet.

Related content which might interest you: FEV6 and FEV1/FEV6 as an alternative for FVC and FEV1/FVC in monitoring response to prednisolone treatment Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010 FEV6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace Source: Eur Respir J 2006; 27: 374-377 Year: 2006 Distinguishing hyperinflation from combined restriction in patients with reduced FEV1/FVC and FVC on spirometry Source: Eur Respir J 2006; 28: Suppl. 50, 202s Year: 2006 FEV6 as an alternative for FVC in predicting airway obstruction Source: Eur Respir J 2006; 28: Suppl. 50, 220s Year: 2006 Is the forced expiratory volume in 6 seconds (FEV6) a more reproducible and accurate measurement than forced vital capacity (FVC) in obstructive and normal/restrictive patients Source: Eur Respir J 2001; 18: Suppl. 33, 13s Year: 2001 Midflows do not vary independently of FEV1 and FVC Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010 FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma. Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020 The inclusion of peak expiratory flow (PEF) among selection criteria of the ”best test“ may increase diagnostic ability of forced vital capacity (FVC) Source: Eur Respir J 2001; 18: Suppl. 33, 202s Year: 2001 Within session variability of FEV1 and FVC pre- and post-bronchodilation Source: International Congress 2019 – Quality, performance and interpretation of lung function testing Year: 2019 Can the prediction point for FEV1 / FVC be determined in patients with insufficient expiratory maneuver to determine airflow obstruction? Source: Virtual Congress 2020 – Advances in lung function testing Year: 2020 Are FEV6, FVC and VC different in diagnosing obstructive ventilatory defect? Source: International Congress 2019 – Physiologic assessment of airway diseases Year: 2019 Using the pre-bronchodilator spirometry curvature to improve estimation of post-bronchodilator airflow obstruction Source: International Congress 2019 – Physiologic assessment of airway diseases Year: 2019 The influence of FVC manoeuvres on consecutive FEV1 values during methacholine challenge Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004 Auscultatory forced expiratory time as a predictor of FEV1 and as a clinical test of airway obstruction Source: Eur Respir J 2004; 24: Suppl. 48, 225s Year: 2004 Use of forced vital capacity and forced expiratory volume in 1 second quality criteria for determining a valid test Source: Eur Respir J 2015; 45: 1283-1292 Year: 2015 Comparison of prebronchodilator FEV1/FEV6 of handheld spirometry with postbronchodilator FEV1/FVC of spirometry in Korea: a pilot study Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017 The acceptability criterion for the difference between the forced inspiratory vital capacity (FIVC) and the forced vital capacity (FVC) are too strict? Source: Virtual Congress 2021 – Future advances in respiratory physiology Year: 2021 FEF25-75% should not yet be used to define a bronchodilator response in individuals Source: Annual Congress 2005 - Spirometry - now and in the future Year: 2005 Reproducibility of FEV6 and FVC measurement: dependence on degree of obstruction Source: Annual Congress 2006 - Landmark developments in lung function testing: 2006 Year: 2006 Prediction of all cause mortality in a population sample is improved by using FEV1 quotient Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005